May 07, 2019 GenSight Biologics announces positive Data Safety Monitoring Board review and continuation of PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa
May 06, 2019 GenSight Biologics announces presentation of 72-week data from the REVERSE Phase III trial of GS010 at the Annual Meeting of the American Academy of Neurology (AAN)
May 01, 2019 Rainier Therapeutics Announces Appointment of Gary Christianson as Chief Technical Officer
May 01, 2019 Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update
April 30, 2019 Pulmonx Announces That HUMANA Has Issued a Positive Coverage Policy for the Zephyr Valve, a Less Invasive Treatment Option for Severe Emphysema (COPD)